- Home
- RCAT vs QURE Comparison
RCAT vs QURE Comparison
Compare RCAT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCAT
- QURE
- Stock Information
- Founded
- RCAT 2002
- QURE 1998
- Country
- RCAT United States
- QURE Netherlands
- Employees
- RCAT N/A
- QURE N/A
- Industry
- RCAT Wholesale Distributors
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- RCAT Industrials
- QURE Health Care
- Exchange
- RCAT Nasdaq
- QURE Nasdaq
- Market Cap
- RCAT 679.1M
- QURE 725.4M
- IPO Year
- RCAT 2017
- QURE 2007
- Fundamental
- Price
- RCAT $9.46
- QURE $15.11
- Analyst Decision
- RCAT Buy
- QURE Strong Buy
- Analyst Count
- RCAT 1
- QURE 10
- Target Price
- RCAT $13.00
- QURE $37.20
- AVG Volume (30 Days)
- RCAT 11.4M
- QURE 1.0M
- Earning Date
- RCAT 08-07-2025
- QURE 07-29-2025
- Dividend Yield
- RCAT N/A
- QURE N/A
- EPS Growth
- RCAT N/A
- QURE N/A
- EPS
- RCAT N/A
- QURE N/A
- Revenue
- RCAT $2,291,089.00
- QURE $20,201,000.00
- Revenue This Year
- RCAT $1,023.35
- QURE N/A
- Revenue Next Year
- RCAT $88.95
- QURE $278.91
- P/E Ratio
- RCAT N/A
- QURE N/A
- Revenue Growth
- RCAT N/A
- QURE 6.30
- 52 Week Low
- RCAT $1.66
- QURE $4.45
- 52 Week High
- RCAT $15.27
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- RCAT 54.45
- QURE 54.26
- Support Level
- RCAT $8.78
- QURE $13.61
- Resistance Level
- RCAT $10.23
- QURE $15.49
- Average True Range (ATR)
- RCAT 1.00
- QURE 0.80
- MACD
- RCAT 0.00
- QURE 0.08
- Stochastic Oscillator
- RCAT 45.91
- QURE 68.27
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.